Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
Corvus Pharmaceuticals (NASDAQ: CRVS) announced that its leadership team will hold one-on-one investor meetings and deliver a fireside chat at the Guggenheim 2nd Annual Healthcare Innovation Conference in Boston.
The fireside chat is scheduled for Monday, November 10, 2025 at 8:30 AM ET. A live webcast will be available and archived for 90 days via the company’s investor relations website.
Corvus Pharmaceuticals (NASDAQ: CRVS) ha annunciato che il suo team dirigenziale terrà incontri individuali con gli investitori e parteciperà a una conversazione informale davanti al pubblico al Guggenheim 2nd Annual Healthcare Innovation Conference a Boston.
La conversazione è prevista per lunedì 10 novembre 2025 alle 8:30 ET. Una trasmissione in diretta sarà disponibile e archiviata per 90 giorni sul sito di relazioni con gli investitori dell'azienda.
Corvus Pharmaceuticals (NASDAQ: CRVS) anunció que su equipo directivo celebrará reuniones individuales con inversionistas y participará en una charla informal durante la Conferencia de Innovación en Salud Guggenheim, segunda edición en Boston.
La charla está programada para el lunes 10 de noviembre de 2025 a las 8:30 a.m. hora del Este. Habrá una transmisión en vivo que también quedará archivada durante 90 días a través del sitio web de relaciones con inversionistas de la empresa.
Corvus Pharmaceuticals (NASDAQ: CRVS)는 리더십 팀이 투자자와의 일대일 미팅을 갖고 보스턴에서 열리는 Guggenheim 2nd Annual Healthcare Innovation Conference에서 fireside chat을 진행할 것이라고 발표했다.
fireside chat은 2025년 11월 10일 월요일, 동부 표준시 8:30 AM에 예정되어 있다. 생중계가 가능하며 회사의 투자자 관계 웹사이트를 통해 90일간 보관될 예정이다.
Corvus Pharmaceuticals (NASDAQ: CRVS) a annoncé que son équipe dirigeante tiendra des réunions individuelles avec les investisseurs et participera à une discussion informelle lors de la Guggenheim 2nd Annual Healthcare Innovation Conference à Boston.
La discussion est prévue pour le lundi 10 novembre 2025 à 8 h 30 HE. Une webdiffusion en direct sera disponible et archivée pendant 90 jours sur le site des relations investisseurs de l'entreprise.
Corvus Pharmaceuticals (NASDAQ: CRVS) gab bekannt, dass das Führungsteam Einzelgespräche mit Investoren führen und an einem Fireside-Chat beim Guggenheim 2nd Annual Healthcare Innovation Conference in Boston teilnehmen wird.
Der Fireside-Chat ist für Montag, 10. November 2025 um 8:30 Uhr Eastern Time geplant. Eine Live-Webcast wird verfügbar sein und für 90 Tage über die Website des Investor Relations archiviert.
شركة Corvus Pharmaceuticals (NASDAQ: CRVS) أعلنت أن فريقها القيادي سيعقد لقاءات فردية مع المستثمرين وسيقدم جلسة دردشة حميمية خلال مؤتمر Guggenheim التاسع للابتكار في الرعاية الصحية في بوسطن.
من المقرر أن تكون الدردشة الحميمية في الاثنين 10 نوفمبر 2025 الساعة 8:30 صباحاً بتوقيت شرق الولايات المتحدة. سيكون هناك بث حي وسيتم أرشفته لمدة 90 يوماً عبر موقع علاقات المستثمرين للشركة.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one-on-one meetings with investors and participate in a fireside chat presentation at the Guggenheim 2nd Annual Healthcare Innovation Conference, which is being held in Boston, MA. The fireside chat will be on Monday, November 10, 2025 at 8:30 am ET.
A webcast of the fireside chat will be available live and for 90 days following the event. The webcast may be accessed via the investor relations section of the Corvus website.
About Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering the development of ITK inhibition as a new approach to immunotherapy for a broad range of cancer and immune diseases. The Company’s lead product candidate is soquelitinib, an investigational, oral, small molecule drug that selectively inhibits ITK. Its other clinical-stage candidates are being developed for a variety of cancer indications. For more information, visit www.corvuspharma.com.
INVESTOR CONTACT:
Leiv Lea
Chief Financial Officer
Corvus Pharmaceuticals, Inc.
+1-650-900-4522
llea@corvuspharma.com
MEDIA CONTACT:
Sheryl Seapy
Real Chemistry
+1-949-903-4750
FAQ
When will Corvus Pharmaceuticals (CRVS) present at the Guggenheim Healthcare Innovation Conference?
How can investors watch the Corvus (CRVS) fireside chat webcast?
Will Corvus (CRVS) leadership meet with investors at the Guggenheim conference?
Where is the Guggenheim 2nd Annual Healthcare Innovation Conference taking place for Corvus (CRVS)?
How long will the Corvus (CRVS) webcast be available after the Guggenheim presentation?
Where on the Corvus site is the Guggenheim webcast hosted?
